HIF-1α suppresses myeloma progression by targeting Mcl-1

被引:1
|
作者
Wu, Feng [1 ]
Tong, Dong-Dong [2 ]
Ni, Lei [2 ]
Wang, Lu-Min [2 ]
Wang, Meng-Chang [3 ]
机构
[1] Xi An Jiao Tong Univ, Ctr Teaching & Expt Med Post Grad, Sch Med, Xian, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Cell Biol & Genet, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hematol, Xian, Shaanxi, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2020年 / 13卷 / 07期
基金
中国国家自然科学基金;
关键词
HIF-1; alpha; Mcl-1; MMs; proliferation; apoptosis; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER; CELLS; PROLIFERATION; APOPTOSIS; PATHWAY; VEGF;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
HIF-1 alpha is involved in the carcinogenesis and progression of multiple types of cancer. However, the precise role of HIF-1 alpha is unclear in multiple myeloma. Through the qRT-PCR and CCK-8 assays, we demonstrated that silenc-ing the expression of HIF-1 alpha and Mcl-1, MM proliferation can be decreased and apoptosis can be induced. Next, using the GEO database, we found that Mcl-1 was increased in MMs. Mcl-1 overexpression counterbalanced the tumor suppressing effect of siHIF-1 alpha on MM apoptosis. Additionally, HIF-1 alpha acting as a transcription factor, could directly target the promoter region of Mcl-1 to promote Mcl-1 expression. Based on the experimental result, our find-ings strongly suggest that HIF-1 alpha regulated the progression of MMs by directly targeting the Mcl-1.
引用
收藏
页码:1483 / +
页数:10
相关论文
共 50 条
  • [21] Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors
    Gores, Gregory J.
    Kaufmann, Scott H.
    GENES & DEVELOPMENT, 2012, 26 (04) : 305 - 311
  • [22] Dual inhibition of Mcl-1 by the combination of carfilzomib and TG02 in multiple myeloma
    Ponder, Katelyn G.
    Matulis, Shannon M.
    Hitosugi, Sadae
    Gupta, Vikas A.
    Sharp, Cathy
    Burrows, Francis
    Nooka, Ajay K.
    Kaufman, Jonathan L.
    Lonial, Sagar
    Boise, Lawrence H.
    CANCER BIOLOGY & THERAPY, 2016, 17 (07) : 769 - 777
  • [23] LANA-1, Bcl-2, Mcl-1 and HIF-1α protein expression in HIV-associated Kaposi sarcoma
    E Long
    M Ilie
    V Hofman
    K Havet
    E Selva
    C Butori
    J P Lacour
    A M Nelson
    G Cathomas
    P Hofman
    Virchows Archiv, 2009, 455 : 159 - 170
  • [24] Targeting Mcl-1 for multiple myeloma (MM) therapy: Drug-induced generation of Mcl-1 fragment Mcl-1128-350 triggers MM cell death via c-Jun upregulation
    Fan, Fengjuan
    Tonon, Giovanni
    Bashari, Muhammad Hasan
    Vallet, Sonia
    Antonini, Elena
    Goldschmidt, Hartmut
    Schulze-Bergkamen, Henning
    Opferman, Joseph T.
    Sattler, Martin
    Anderson, Kenneth C.
    Jaeger, Dirk
    Podar, Klaus
    CANCER LETTERS, 2014, 343 (02) : 286 - 294
  • [25] LANA-1, Bcl-2, Mcl-1 and HIF-1α protein expression in HIV-associated Kaposi sarcoma
    Long, E.
    Ilie, M.
    Hofman, V.
    Havet, K.
    Selva, E.
    Butori, C.
    Lacour, J. P.
    Nelson, A. M.
    Cathomas, G.
    Hofman, P.
    VIRCHOWS ARCHIV, 2009, 455 (02) : 159 - 170
  • [26] Mcl-1
    Michels, J
    Johnson, PWM
    Packham, G
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (02) : 267 - 271
  • [27] Acevaltrate promotes apoptosis and inhibits proliferation by suppressing HIF-1α accumulation in cancer cells
    Mi, Chunliu
    Zhang, Qiu-Li
    Sun, Meng-Jun
    Lv, You
    Sun, Qiu-Li
    Geng, Shao-Lei
    Wang, Tian-Yun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 133
  • [28] HIF-1α has an anti-apoptotic effect in human airway epithelium that is mediated via Mcl-1 gene expression
    Liu, XH
    Yu, EZ
    Li, YY
    Kagan, E
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 97 (04) : 755 - 765
  • [29] Multiple myeloma with amplification of chromosome 1q is highly sensitive to MCL-1 targeting
    Slomp, Anne
    Moesbergen, Laura
    Gong, Jia-nan
    Cuenca, Marta
    Borne, Peter von dem
    Sonneveld, Pieter
    Huang, David
    Minnema, Monique
    Peperzak, Victor
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) : E49 - E50
  • [30] Targeting TRMT5 suppresses hepatocellular carcinoma progression via inhibiting the HIF-1α pathways
    Zhao, Qiong
    Zhang, Luwen
    He, Qiufen
    Chang, Hui
    Wang, Zhiqiang
    Cao, Hongcui
    Zhou, Ying
    Pan, Ruolang
    Chen, Ye
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2023, 24 (01): : 50 - 63